213 related articles for article (PubMed ID: 32085430)
1. An Oleanolic Acid Derivative Inhibits Hemagglutinin-Mediated Entry of Influenza A Virus.
Ye M; Liao Y; Wu L; Qi W; Choudhry N; Liu Y; Chen W; Song G; Chen J
Viruses; 2020 Feb; 12(2):. PubMed ID: 32085430
[TBL] [Abstract][Full Text] [Related]
2. New small molecule entry inhibitors targeting hemagglutinin-mediated influenza a virus fusion.
Basu A; Antanasijevic A; Wang M; Li B; Mills DM; Ames JA; Nash PJ; Williams JD; Peet NP; Moir DT; Prichard MN; Keith KA; Barnard DL; Caffrey M; Rong L; Bowlin TL
J Virol; 2014 Feb; 88(3):1447-60. PubMed ID: 24198411
[TBL] [Abstract][Full Text] [Related]
3. Quercetin as an Antiviral Agent Inhibits Influenza A Virus (IAV) Entry.
Wu W; Li R; Li X; He J; Jiang S; Liu S; Yang J
Viruses; 2015 Dec; 8(1):. PubMed ID: 26712783
[TBL] [Abstract][Full Text] [Related]
4. CL-385319 inhibits H5N1 avian influenza A virus infection by blocking viral entry.
Liu S; Li R; Zhang R; Chan CC; Xi B; Zhu Z; Yang J; Poon VK; Zhou J; Chen M; Münch J; Kirchhoff F; Pleschka S; Haarmann T; Dietrich U; Pan C; Du L; Jiang S; Zheng B
Eur J Pharmacol; 2011 Jun; 660(2-3):460-7. PubMed ID: 21536025
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of the action of povidone-iodine against human and avian influenza A viruses: its effects on hemagglutination and sialidase activities.
Sriwilaijaroen N; Wilairat P; Hiramatsu H; Takahashi T; Suzuki T; Ito M; Ito Y; Tashiro M; Suzuki Y
Virol J; 2009 Aug; 6():124. PubMed ID: 19678928
[TBL] [Abstract][Full Text] [Related]
6. Identification of entry inhibitors with 4-aminopiperidine scaffold targeting group 1 influenza A virus.
Hussein AFA; Cheng H; Tundup S; Antanasijevic A; Varhegyi E; Perez J; AbdulRahman EM; Elenany MG; Helal S; Caffrey M; Peet N; Manicassamy B; Rong L
Antiviral Res; 2020 May; 177():104782. PubMed ID: 32222293
[TBL] [Abstract][Full Text] [Related]
7. Porous gold nanoparticles for attenuating infectivity of influenza A virus.
Kim J; Yeom M; Lee T; Kim HO; Na W; Kang A; Lim JW; Park G; Park C; Song D; Haam S
J Nanobiotechnology; 2020 Mar; 18(1):54. PubMed ID: 32209114
[TBL] [Abstract][Full Text] [Related]
8. Influenza A virus entry inhibitors targeting the hemagglutinin.
Yang J; Li M; Shen X; Liu S
Viruses; 2013 Jan; 5(1):352-73. PubMed ID: 23340380
[TBL] [Abstract][Full Text] [Related]
9. Novel inhibitors of influenza virus fusion: structure-activity relationship and interaction with the viral hemagglutinin.
Vanderlinden E; Göktas F; Cesur Z; Froeyen M; Reed ML; Russell CJ; Cesur N; Naesens L
J Virol; 2010 May; 84(9):4277-88. PubMed ID: 20181685
[TBL] [Abstract][Full Text] [Related]
10. Sialic acid-mimic peptides as hemagglutinin inhibitors for anti-influenza therapy.
Matsubara T; Onishi A; Saito T; Shimada A; Inoue H; Taki T; Nagata K; Okahata Y; Sato T
J Med Chem; 2010 Jun; 53(11):4441-9. PubMed ID: 20476787
[TBL] [Abstract][Full Text] [Related]
11. 3-O-galloylated procyanidins from Rumex acetosa L. inhibit the attachment of influenza A virus.
Derksen A; Hensel A; Hafezi W; Herrmann F; Schmidt TJ; Ehrhardt C; Ludwig S; Kühn J
PLoS One; 2014; 9(10):e110089. PubMed ID: 25303676
[TBL] [Abstract][Full Text] [Related]
12. Aryl Sulfonamide Inhibits Entry and Replication of Diverse Influenza Viruses via the Hemagglutinin Protein.
White K; Esparza M; Liang J; Bhat P; Naidoo J; McGovern BL; Williams MAP; Alabi BR; Shay J; Niederstrasser H; Posner B; García-Sastre A; Ready J; Fontoura BMA
J Med Chem; 2021 Aug; 64(15):10951-10966. PubMed ID: 34260245
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of influenza A virus (H1N1) fusion by benzenesulfonamide derivatives targeting viral hemagglutinin.
Zhu L; Li Y; Li S; Li H; Qiu Z; Lee C; Lu H; Lin X; Zhao R; Chen L; Wu JZ; Tang G; Yang W
PLoS One; 2011; 6(12):e29120. PubMed ID: 22195002
[TBL] [Abstract][Full Text] [Related]
14. Biological evaluation of anti-influenza viral activity of semi-synthetic catechin derivatives.
Song JM; Park KD; Lee KH; Byun YH; Park JH; Kim SH; Kim JH; Seong BL
Antiviral Res; 2007 Nov; 76(2):178-85. PubMed ID: 17709148
[TBL] [Abstract][Full Text] [Related]
15. An induced pocket for the binding of potent fusion inhibitor CL-385319 with H5N1 influenza virus hemagglutinin.
Li R; Song D; Zhu Z; Xu H; Liu S
PLoS One; 2012; 7(8):e41956. PubMed ID: 22876294
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of influenza A virus infection in vitro by peptides designed in silico.
López-Martínez R; Ramírez-Salinas GL; Correa-Basurto J; Barrón BL
PLoS One; 2013; 8(10):e76876. PubMed ID: 24146939
[TBL] [Abstract][Full Text] [Related]
17. Different pH requirements are associated with divergent inhibitory effects of chloroquine on human and avian influenza A viruses.
Di Trani L; Savarino A; Campitelli L; Norelli S; Puzelli S; D'Ostilio D; Vignolo E; Donatelli I; Cassone A
Virol J; 2007 May; 4():39. PubMed ID: 17477867
[TBL] [Abstract][Full Text] [Related]
18. A histidine residue of the influenza virus hemagglutinin controls the pH dependence of the conformational change mediating membrane fusion.
Mair CM; Meyer T; Schneider K; Huang Q; Veit M; Herrmann A
J Virol; 2014 Nov; 88(22):13189-200. PubMed ID: 25187542
[TBL] [Abstract][Full Text] [Related]
19. Super short membrane-active lipopeptides inhibiting the entry of influenza A virus.
Wu W; Wang J; Lin D; Chen L; Xie X; Shen X; Yang Q; Wu Q; Yang J; He J; Liu S
Biochim Biophys Acta; 2015 Oct; 1848(10 Pt A):2344-50. PubMed ID: 26092189
[TBL] [Abstract][Full Text] [Related]
20. New influenza A Virus Entry Inhibitors Derived from the Viral Fusion Peptides.
Wu W; Lin D; Shen X; Li F; Fang Y; Li K; Xun T; Yang G; Yang J; Liu S; He J
PLoS One; 2015; 10(9):e0138426. PubMed ID: 26382764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
